APAC Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029
Description
APAC Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029
Asia-Pacific left ventricular device (LVAD) market is projected to register a substantial CAGR of 8.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Asia-Pacific Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends & Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific left ventricular device (LVAD) market are:
. Increased hospitalization costs for heart failure.
. Increase in healthcare expenditure
Market Players:
The key market players for Asia-Pacific left ventricular device (LVAD) market are listed below:
. ABIOMED
. Abbott
. Saft
. Berlin Heart
. CorWave SA
. Jarvik Heart, Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Asia-Pacific left ventricular device (LVAD) market is projected to register a substantial CAGR of 8.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Asia-Pacific Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends & Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific left ventricular device (LVAD) market are:
. Increased hospitalization costs for heart failure.
. Increase in healthcare expenditure
Market Players:
The key market players for Asia-Pacific left ventricular device (LVAD) market are listed below:
. ABIOMED
. Abbott
. Saft
. Berlin Heart
. CorWave SA
. Jarvik Heart, Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
274 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Asia Pacific Left Ventricular Assist Device (Lvad) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel
- 4.2 Porter's
- 4.3 Industrial Insights:
- 5 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Regulations
- 5.1 Regulation In U.S.
- 5.1.1 Guidelines-
- 5.2 Regulation In Europe
- 5.2.1 Guidelines For The Manufacturers:
- 5.3 Regulation In Canada
- 5.3.1 Guidelines For The Manufacturers:
- 5.4 Regulation In Mexico
- 5.4.1 Guidelines For The Manufacturers:
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increasing Geriatric Population Along With Rising Prevalence Of Cardiac Diseases
- 6.1.2 Presence Of Favourable Reimbursement Policies
- 6.1.3 Changing Lifestyle Triggers The Development Of Cardiovascular Diseases
- 6.2 Restraints
- 6.2.1 High Cost Of Lvad Implantation And Treatment
- 6.2.2 Complications And Risks Associated With Lvad
- 6.3 Opportunities
- 6.3.1 Increase In Healthcare Expenditure
- 6.3.2 Increase In Minimally Invasive Procedure
- 6.3.3 Increasing Shortage Of Organ Donors
- 6.3.4 Technological Advancements In Left Ventricular Assist Devices
- 6.4 Challenges
- 6.4.1 Ongoing Covid-19
- 6.4.2 Increase In Product Recall
- 7 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Product Type
- 7.1 Overview
- 7.2 Heart Pump
- 7.3 Controller
- 7.4 Batteries
- 7.4.1 Rechargeable
- 7.4.2 Non-rechargeable
- 7.5 Wires
- 8 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Therapy
- 8.1 Overview
- 8.2 Bridge-to-transplant (Btt) Therapy
- 8.2.1 Heart Pump
- 8.2.2 Controller
- 8.2.3 Batteries
- 8.2.4 Wires
- 8.3 Destination Therapy
- 8.3.1 Heart Pump
- 8.3.2 Controller
- 8.3.3 Batteries
- 8.3.4 Wires
- 8.4 Bridge-to-candidacy (Btc) Therapy
- 8.4.1 Heart Pump
- 8.4.2 Controller
- 8.4.3 Batteries
- 8.4.4 Wires
- 8.5 Bridge-to-recovery (Btr) Therapy
- 8.5.1 Heart Pump
- 8.5.2 Controller
- 8.5.3 Batteries
- 8.5.4 Wires
- 9 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Age Group
- 9.1 Overview
- 9.2 Adult
- 9.2.1 19-39 Years
- 9.2.2 40-59 Years
- 9.2.3 60-79 Years
- 9.2.4 Above 80 Years
- 9.3 Pediatric
- 10 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Generation
- 10.1 Overview
- 10.2 Second Generation Devices
- 10.3 Third Generation Devices
- 10.4 First Generation Devices
- 11 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Design
- 11.1 Overview
- 11.2 Axial
- 11.3 Centrifugal
- 12 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Indication
- 12.1 Overview
- 12.2 Congestive Heart Failure
- 12.2.1 Heart Pump
- 12.2.2 Controller
- 12.2.3 Batteries
- 12.2.4 Wires
- 12.3 Congenital Heart Disease
- 12.3.1 Heart Pump
- 12.3.2 Controller
- 12.3.3 Batteries
- 12.3.4 Wires
- 12.4 Myocarditis
- 12.4.1 Heart Pump
- 12.4.2 Controller
- 12.4.3 Batteries
- 12.4.4 Wires
- 12.5 Cardiac Arrest
- 12.5.1 Heart Pump
- 12.5.2 Controller
- 12.5.3 Batteries
- 12.5.4 Wires
- 12.6 Familial Arrhythmias And Arrhythmic Cardiomyopathies
- 12.6.1 Heart Pump
- 12.6.2 Controller
- 12.6.3 Batteries
- 12.6.4 Wires
- 12.7 Advanced Heart Failure
- 12.7.1 Heart Pump
- 12.7.2 Controller
- 12.7.3 Batteries
- 12.7.4 Wires
- 12.8 Others
- 13 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market, By Durability
- 13.1 Overview
- 13.2 Long-term
- 13.3 Intermediate-term
- 13.4 Short-term
- 14 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market, By Pulse Type
- 14.1 Overview
- 14.2 Nonpulsatile
- 14.3 Pulsatile
- 15 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market, By End User
- 15.1 Overview
- 15.2 Hospital
- 15.3 Cardiac Cath Laboratories
- 15.4 Specialty Clinics
- 15.5 Others
- 16 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market, By Distribution Channel
- 16.1 Overview
- 16.2 Direct Tender
- 16.3 Retail Sales
- 16.4 Others
- 17 Asia Pacific Left Ventricular Assist Device (Lvad) Market, By Region
- 17.1 Asia-pacific
- 17.1.1 Japan
- 17.1.2 China
- 17.1.3 South Korea
- 17.1.4 India
- 17.1.5 Australia
- 17.1.6 Singapore
- 17.1.7 Thailand
- 17.1.8 Malaysia
- 17.1.9 Philippines
- 17.1.10 Indonesia
- 17.1.11 Rest Of Asia-pacific
- 18 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Company Landscape
- 18.1 Company Share Analysis: Asia Pacific
- 19 Swot Analysis
- 20 Company Profile
- 20.1 Abiomed
- 20.1.1 Company Snapshot
- 20.1.2 Revenue Analysis
- 20.1.3 Company Share Analysis
- 20.1.4 Product Portfolio
- 20.1.5 Recent Developments
- 20.1.5.1 Fda Approval
- 20.1.5.2 Fda Approval
- 20.2 Abbott
- 20.2.1 Company Snapshot
- 20.2.2 Revenue Analysis
- 20.2.3 Company Share Analysis
- 20.2.4 Product Portfolio
- 20.2.5 Recent Developments
- 20.2.5.1 Supply Increment
- 20.2.5.2 Break Through Device Designation
- 20.3 Berlin Heart
- 20.3.1 Company Snapshot
- 20.3.2 Company Share Analysis
- 20.3.3 Product Portfolio
- 20.3.4 Recent Development
- 20.3.4.1 Product Approval
- 20.4 Saft (A Subsidiary Of Totalenergies)
- 20.4.1 Company Snapshot
- 20.4.2 Revenue Analysis
- 20.4.3 Company Share Analysis
- 20.4.4 Product Portfolio
- 20.4.5 Recent Development
- 20.4.5.1 Partnership
- 20.5 Jarvik Heart, Inc.
- 20.5.1 Company Snapshot
- 20.5.2 Company Share Analysis
- 20.5.3 Product Portfolio
- 20.5.4 Recent Development
- 20.5.4.1 Fda Approval
- 20.6 Corwave Sa
- 20.6.1 Company Snapshot
- 20.6.2 Product Portfolio
- 20.6.3 Recent Development
- 20.6.3.1 Expansion
- 20.7 Evaheart, Inc
- 20.7.1 Company Snapshot
- 20.7.2 Product Portfolio
- 20.7.3 Recent Development
- 20.7.3.1 Product Trial
- 21 Questionnaire
- 22 Related Reports
- List Of Figures
- Figure 1 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Segmentation
- Figure 2 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Data Triangulation
- Figure 3 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Droc Analysis
- Figure 4 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Asia Pacific Vs Regional Analysis
- Figure 5 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Company Research Analysis
- Figure 6 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Interview Demographics
- Figure 7 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Dbmr Market Position Grid
- Figure 8 Asia Pacific Left Ventricular Assist Device (Lvad) Market: End User Coverage Grid
- Figure 9 Asia Pacific Left Ventricular Assist Device (Lvad) Market:vendor Share Analysis
- Figure 10 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Segmentation
- Figure 11 Increasing Prevalence Of Cardiovascular Disease And Rising Healthcare Expenditure Are Expected To Drive The Asia Pacific Left Ventricular Assist Device (Lvad) Market In The Forecast Period Of 2022 To 2029
- Figure 12 Heart Pump Segment Is Expected To Account For The Largest Share Of The Asia Pacific Left Ventricular Assist Device (Lvad) Market In 2022 & 2029
- Figure 13 North America Is Expected To Dominate The Asia Pacific Left Ventricular Assist Device (Lvad) Market And Asia-pacific To Grow With The Highest Cagr In The Forecast Period Of 2022 To 2029
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Asia Pacific Left Ventricular Assist Device (Lvad) Market
- Figure 15 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Product Type, 2021
- Figure 16 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Product Type, 2020-2029 (Usd Million)
- Figure 17 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Product Type, Cagr (2022-2029)
- Figure 18 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Product Type, Lifeline Curve
- Figure 19 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Therapy, 2021
- Figure 20 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Therapy, 2020-2029 (Usd Million)
- Figure 21 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Therapy, Cagr (2022-2029)
- Figure 22 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Therapy, Lifeline Curve
- Figure 23 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Age Group, 2021
- Figure 24 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Age Group, 2020-2029 (Usd Million)
- Figure 25 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Age Group, Cagr (2022-2029)
- Figure 26 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Age Group, Lifeline Curve
- Figure 27 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Generation, 2021
- Figure 28 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Generation, 2020-2029 (Usd Million)
- Figure 29 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Generation, Cagr (2022-2029)
- Figure 30 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Generation, Lifeline Curve
- Figure 31 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Design, 2021
- Figure 32 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Design, 2020-2029 (Usd Million)
- Figure 33 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Design, Cagr (2022-2029)
- Figure 34 Asia Pacific Left Ventricular Assist Device (Lvad) Market: By Design, Lifeline Curve
- Figure 35 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Indication, 2021
- Figure 36 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Indication, 2020-2029 (Usd Million)
- Figure 37 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Indication, Cagr (2022-2029)
- Figure 38 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Indication, Lifeline Curve
- Figure 39 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Durability, 2021
- Figure 40 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Durability, 2020-2029 (Usd Million)
- Figure 41 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Durability, Cagr (2022-2029)
- Figure 42 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Durability, Lifeline Curve
- Figure 43 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, 2021
- Figure 44 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, 2020-2029 (Usd Million)
- Figure 45 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, Cagr (2022-2029)
- Figure 46 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, Lifeline Curve
- Figure 47 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By End User, 2021
- Figure 48 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By End User, 2020-2029 (Usd Million)
- Figure 49 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By End User, Cagr (2022-2029)
- Figure 50 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By End User, Lifeline Curve
- Figure 51 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, 2021
- Figure 52 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, 2020-2029 (Usd Million)
- Figure 53 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, Cagr (2022-2029)
- Figure 54 Asia Pacific Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, Lifeline Curve
- Figure 55 Asia-pacific Left Ventricular Assist Device (Lvad) Market: Snapshot (2021)
- Figure 56 Asia-pacific Left Ventricular Assist Device (Lvad) Market: By Country (2021)
- Figure 57 Asia-pacific Left Ventricular Assist Device (Lvad) Market: By Country (2022 & 2029)
- Figure 58 Asia-pacific Left Ventricular Assist Device (Lvad) Market: By Country (2021 & 2029)
- Figure 59 Asia-pacific Left Ventricular Assist Device (Lvad) Market: By Product Type (2022-2029)
- Figure 60 Asia Pacific Left Ventricular Assist Device (Lvad) Market: Company Share 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


